|
PH31122A
(en)
|
1993-03-31 |
1998-02-23 |
Eisai Co Ltd |
Nitrogen-containing fused-heterocycle compounds.
|
|
JP4342007B2
(ja)
*
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
|
PT1725540E
(pt)
|
2004-03-05 |
2012-11-29 |
Hoffmann La Roche |
Diaminopirimidinas como antagonistas de p2x3 e p2x2/3
|
|
SI1924264T1
(sl)
*
|
2005-09-01 |
2013-12-31 |
F. Hoffmann-La Roche Ag |
Diaminopirimidini kot modulatorji p2x3 in p2x2/3
|
|
WO2007134986A1
(en)
|
2006-05-23 |
2007-11-29 |
F. Hoffmann-La Roche Ag |
Pyridopyrimidinone derivatives
|
|
ES2596706T3
(es)
|
2006-06-29 |
2017-01-11 |
F. Hoffmann-La Roche Ag |
Arilamidas con sustitución de tetrazol
|
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008123963A1
(en)
|
2007-04-02 |
2008-10-16 |
Renovis, Inc. |
Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
|
|
US8076345B2
(en)
|
2007-04-17 |
2011-12-13 |
Evotec Ag |
2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
|
|
WO2009110985A2
(en)
|
2008-02-29 |
2009-09-11 |
Renovis, Inc. |
Amide compounds, compositions and uses thereof
|
|
US20110237578A1
(en)
|
2008-09-18 |
2011-09-29 |
Zhi-Liang Wei |
Amide compounds, compositions and uses thereof
|
|
JP2012504157A
(ja)
|
2008-09-30 |
2012-02-16 |
アストラゼネカ アクチボラグ |
複素環式jakキナーゼ阻害剤
|
|
SG173647A1
(en)
|
2009-02-13 |
2011-10-28 |
Shionogi & Co |
Novel triazine derivative and pharmaceutical composition containing same
|
|
WO2011041655A1
(en)
*
|
2009-10-01 |
2011-04-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Quinazolin-4-amine derivatives; and methods of use
|
|
WO2012064973A2
(en)
*
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP2938600B1
(en)
|
2012-12-27 |
2017-01-25 |
F. Hoffmann-La Roche AG |
Comt inhibitors
|
|
WO2016053794A1
(en)
|
2014-09-30 |
2016-04-07 |
Bristol-Myers Squibb Company |
Quinazoline-based kinase inhibitors
|
|
WO2016084922A1
(ja)
|
2014-11-28 |
2016-06-02 |
塩野義製薬株式会社 |
1,2,4-トリアジン誘導体およびその医薬組成物
|
|
WO2016088838A1
(ja)
|
2014-12-04 |
2016-06-09 |
塩野義製薬株式会社 |
プリン誘導体およびその医薬組成物
|
|
CU24411B1
(es)
|
2014-12-09 |
2019-05-03 |
Bayer Ag |
Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos
|
|
WO2017011729A1
(en)
|
2015-07-16 |
2017-01-19 |
Patara Pharma, LLC |
Combination therapies for the treatment of lung diseases
|
|
CA2998742C
(en)
|
2015-09-29 |
2023-08-29 |
Anthony P. FORD |
Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough
|
|
EP3380469B1
(en)
*
|
2015-11-25 |
2022-03-16 |
Convergene Llc |
Bicyclic bet bromodomain inhibitors and uses thereof
|
|
CN106565684B
(zh)
|
2016-03-18 |
2019-06-18 |
南方医科大学 |
6-吡唑取代喹唑啉类化合物及其衍生物、合成方法及其应用
|
|
JP6776378B2
(ja)
|
2016-06-30 |
2020-10-28 |
ギリアード サイエンシーズ, インコーポレイテッド |
Cotモジュレーターとしての4,6−ジアミノキナゾリン類およびその使用方法
|
|
GB201700814D0
(en)
*
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
TWI762634B
(zh)
|
2017-05-05 |
2022-05-01 |
大陸商上海赫普化醫藥技術有限公司 |
胺基-芳基-苯甲醯胺化合物及其使用方法
|
|
DK3827005T3
(da)
*
|
2018-07-25 |
2022-09-19 |
Faes Farma Sa |
Pyridopyrimidiner som histamin H4-receptorhæmmere
|
|
CN109721554A
(zh)
|
2019-01-08 |
2019-05-07 |
贵州大学 |
一类4-氨基喹唑啉类化合物及其制备方法和应用
|
|
MA56022A
(fr)
*
|
2019-05-31 |
2022-04-06 |
Chiesi Farm Spa |
Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
|
|
KR102923602B1
(ko)
|
2019-05-31 |
2026-02-06 |
키에시 파르마슈티시 엣스. 피. 에이. |
P2x3 억제제로서 피리도피리미딘 유도체
|